Brachytherapy for genital-tract rhabdomyosarcomas in girls: technical aspects, reports, and perspectives

Lancet Oncology

Volumn 8, Issue 8, 2007, Pages 725-729

  Magné, Nicolas ^a   Haie Meder, Christine ^a  

^a INSTITUT GUSTAVE ROUSSY   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT; IRIDIUM 192;

BRACHYTHERAPY; CANCER GRADING; CANCER LOCALIZATION; CANCER SIZE; CANCER SURVIVAL; CHILDHOOD CANCER; CLINICAL FEATURE; DOSIMETRY; DRUG EFFICACY; FEMALE; FEMALE GENITAL TRACT CANCER; FOLLOW UP; GYNECOLOGIC SURGERY; HISTOPATHOLOGY; HUMAN; HYSTERECTOMY; LOW ENERGY RADIATION; MULTIMODALITY CANCER THERAPY; OUTCOME ASSESSMENT; OVERALL SURVIVAL; PATHOLOGICAL ANATOMY; PRIORITY JOURNAL; RADIATION HAZARD; REVIEW; RHABDOMYOSARCOMA; SURGICAL TECHNIQUE; SURVIVAL RATE; SURVIVAL TIME; TELANGIECTASIA; TREATMENT INDICATION;

ADOLESCENT; ADULT; BRACHYTHERAPY; CHILD; FEMALE; GENITAL NEOPLASMS, FEMALE; HUMANS; PROGNOSIS; RHABDOMYOSARCOMA;

EID: 34547432190     PISSN: 14702045     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1470-2045(07)70240-1     Document Type: Review

References (29)

1. Gatta G., Capocaccia R., Stiller C., et al. Childhood cancer survival trends in Europe: a EUROCARE Working Group study. J Clin Oncol 23 (2005) 3742-3751
2. Nag S., and Tippin D. Brachytherapy for pediatric tumor. Brachytherapy 2 (2003) 131-138
3. Rodary C., Rey A., Rezvani A., and Flamant F. Prognostic factors in rhabdomyosarcomas in childhood. Study carried out with 253 children registered by the International Society of Pediatric Oncology. Bull Cancer 75 (1988) 213-223
4. Ober W., Palmer R., and Glassy F. Rhabdomyosarcoma of the vulva and vagina. AMA Arch Pathol 56 (1953) 364-373
5. Nag S., Grecula J., and Ruymann F. Aggressive chemotherapy, organ-preserving surgery, and high-dose-rate remote brachytherapy in the treatement of rhabdomyosarcoma in infants and young children. Cancer 72 (1993) 2769-2776
6. Arndt C., Donaldson S., Anderson J., et al. What constitutes optimal therapy for patients with rhabdomyosarcoma of the female genital tract?. Cancer 91 (2001) 2454-2468
7. Spunt S., Sweeney T., Hudson M., et al. Late effects of pelvic rhabdomyosarcoma and its treatment in female survivors. J Clin Oncol 23 (2005) 7143-7151
8. Mansky P., Arai A., Stratton P., et al. Treatment late effects in long-term survivors of pediatric sarcoma. Pediatr Blood Cancer 48 (2007) 192-199
9. Sklar C., Mertens A., Mitby P., et al. Premature menopause in survivors of childhood cancer: a report from the childhood cancer survivor study. J Natl Cancer Inst 13 (2006) 890-896
10. Gerbaulet A., Panis X., Flamant F., and Chassagne D. Iridium afterloading curietherapy in the treatment of pediatric malignancies. The Institut Gustave Roussy experience. Cancer 56 (1985) 1274-1279
11. Gerbaulet A., Esche B., Haie-Meder C., et al. Conservative treatment for lower gynecological tract malignancies in children and adolescents: the Institut Gustave-Roussy experience. Int J Radiat Oncol Biol Phys 17 (1989) 655-658
12. Flamant F., Chassagne D., Cosset J., et al. Embryonal rhabdomyosarcoma of the vagina in children. Conservative treatment with curietherapy and chemotherapy. Eur J Cancer 15 (1979) 527-532
13. Flamant F., Gerbaulet A., Nihoul-Fekete C., et al. Long-term sequelae of conservative treatment by surgery, brachytherapy, and chemotherapy for vulval and vaginal rhabdomyosarcoma in children. J Clin Oncol 8 (1990) 1847-1853
14. Flamant F., Rodary C., Rey A., et al. Treatment of non-metastatic rhabdomyosarcoma in childhood and adolescence. Results of the second study of the International Society of Paediatric Oncology: MMT84. Eur J Cancer 34 (1998) 1050-1062
15. Martelli H., Oberlin O., Rey A., et al. Conservative treatment for girls with nonmetastatic rhabdomyosarcoma of the genital tract: a report from the study committee of the International Society of Pediatric Oncology. J Clin Oncol 17 (1999) 2117-2122
16. Magné N., Oberlin O., Martelli H., et al. Vulval and vaginal rhabdomyosarcoma in children:the Institut Gustave Roussy brachytherapy experience with a particular attention on long term outcome. Int J Gynecol Cancer 16 suppl 3 (2006) 610 (abstr 38).
17. Raney Jr. R., Gehan E., Hays D., et al. Primary chemotherapy with or without radiation therapy and/or surgery for children with localized sarcoma of the bladder, prostate, vagina, uterus, and cervix. A comparison of the results in Intergroup Rhabdomyosarcoma Studies I and II. Cancer 66 (1990) 2072-2081
18. Hays D., Shimada H., Raney Jr. R., et al. Clinical staging and treatment results in rhabdomyosarcoma of the female genital tract among children and adolescents. Cancer 61 (1988) 1893-1903
19. Fleming I., Etcubanas E., Patterson R., et al. The role of surgical resection when combined with chemotherapy and radiation in the management of pelvic rhabdomyosarcoma. Ann Surg 199 (1984) 509-514
20. Filipas D., Fisch M., Stein R., et al. Rhabdomyosarcoma of the bladder, prostate or vagina: the role of surgery. BJU Int 93 (2004) 125-129
21. Corpron C., Andrassy R., Hays D., et al. Conservative management of uterine rhabdomyosarcoma: a report from the Intergroup Rhabdomyosarcoma Study III and IV pilot. J Pediatr Surg 30 (1995) 942-944
22. Duel B., Hendren W., Bauer S., et al. Reconstructive options in genitourinary rhabdomyosarcoma. J Urol 156 (1996) 1798-1804
23. Heij H., Vos A., de Kraker J., and Voute P. Urogenital rhabdomyosarcoma in children: is a conservative surgical approach justified?. J Urol 150 (1993) 165-168
24. Healey E., Shamberger R., Grier H., et al. A 10-year experience of pediatric brachytherapy. Int J Radiat Oncol Biol Phys 32 (1995) 451-455
25. Gerbaulet A., Haie C., Michel G., et al. Combined radio-surgical treatment in early invasive cervix carcinoma according to prognostic factors. Experience of the Gustave-Roussy Institute. Eur J Gynaecol Oncol 13 (1992) 256-261
26. Critchley H., and Wallace W. Impact of cancer treatment on uterine function. J Natl Cancer Inst Monogr 34 (2005) 64-68
27. Haie-Meder C., Morice P., Paris B., et al. Consequences of brachytherapy (BT) on uterine myocontractility. Radiother Oncol 71 (2004) S54
28. Arndt C., Donaldson S., Anderson J., et al. What constitutes optimal therapy for patients with rhabdomyosarcoma of the female genital tract?. Cancer 91 (2001) 2454-2468
29. Leuschner I., Harms D., Mattke A., et al. Rhabdomyosarcoma of the urinary bladder and vagina. A clinicopathologic study with emphasis on recurrent disease: a report from the Kiel pediatric tumor registry and the German CWS study. Am J Surg Pathol 25 (2001) 856-864